Report Details:
15 Companies Covered
200 Pages
Market Highlights
The Stem Cell Therapy Market Size was estimated at 0.13 USD Billion in 2024. The market is projected to grow from USD 0.1471 Billion in 2025 to USD 0.5066 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 13.16% during the forecast period 2025 - 2035.
Stem cell therapy includes the use of stem cells to treat or prevent a disease or condition. The main factors expected to drive the market growth are the increasing prevalence of chronic disorders, the growing pharmaceutical industry, and increasing spending on medical research.
The growth of the global stem cell therapy market is attributed to the growing prevalence of chronic diseases and the growing pharmaceutical industry with increased spending on medical research. Furthermore, an increase in the number of clinical studies for stem cell therapy is, driving the market growth. However, the ethical concerns related to embryonic stem cell-based therapies and the associated high costs may hamper the market growth.
MRFR recognizes the following companies as the key players in the global stem cell therapy market—Seraxis, Inc. (Germany), ViaCyte, Inc. (US), Betalin Therapeutics Ltd (Israel), NextCell Pharma AB (US), Kadimastem (Israel), Vertex Pharmaceuticals (US), Fresenius Medical Care AG & Co. KGaA (Germany), Sernava Corp (Canada), Novo Nordisk A/S (Denmark),and Generex Biotechnology (Canada).
Segment Analysis
The global stem cell therapy market has been divided based on cell source, type, application, and end user.The market, based on cell source, has been segregated into adipose tissue, bone marrow, Embryo/Cord Blood-Derived, Neural, IPSCs, and PPSCs.
The market, based on type, is segmented into allogenic and autologous.The global stem cell therapy market, on the basis of application, is segmented into diabetes, musculoskeletal disorders, cancer, cardiovascular disorders, gastrointestinal diseases, and others.The global stem cell therapy market, on the basis of end user, is segmented into hospitals & clinics, academic research centers, and others.
Regional Analysis
The global stem cell therapy market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to dominate with the largest market share due to increased public-private financing and research grants for producing safe and effective stem cell therapy products.
The presence of key players in the region is the primaryfactor driving America’s stem cell therapy market. For instance, in April 2018, Sangamo Therapeutics, Inc., US, received a USD 8 million grant from the California Institute for Regenerative Medicine (CIRM) to evaluate ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia.
Europe holds the second-largest market share due to the increased willingness of patients to undergo stem cell treatment and a growing number of cases of chronic and neurological disorders. For instance, according to GLOBOCAN’s Global Cancer Statistics 2020, there were an estimated 19.3 million new cancer cases and around 10 million cancer deaths.
Asia-Pacific is the fastest-growing regional market for stem cell therapies as it is developing rapidly and has witnessed the emergence of many players. Moreover, the rising prevalence of cancer, and growing adoption of stem cell therapy treatments in the region, are likely to drive the market’s growth.
Key Findings of the Study
- North America remains the largest market for stem cell therapy, driven by significant investments in research and development.
- The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare expenditures and a growing patient population.
- Cell therapy continues to dominate the market, while regenerative medicine is rapidly gaining traction due to its innovative approaches.
- Key market drivers include the increasing prevalence of chronic diseases and rising investment in regenerative medicine, which are shaping the industry's future.
